HS-IT201 injection for advanced solid tumors
Part of Cancer clinical trials.
This trial tests an experimental cell therapy for people with advanced solid tumors that have not responded to standard treatments. The therapy uses immune cells from your own tumor, grown in the lab and given back to you, potentially to help your body fight the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have advanced cancer that has not responded to or you cannot tolerate standard treatments (such as kidney, lung, stomach, colon, or melanoma).
- You must have at least one tumor that can be removed for this therapy (and it is big enough).
- You must have at least one other measurable tumor that can be tracked with scans.
- You feel well enough to carry out daily activities (performance status 0 or 1) and have a life expectancy of more than 3 months.
- Your heart, lungs, liver, kidneys, and blood counts are within acceptable levels as per the study doctors' tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental cell therapy (HS-IT101) for people with advanced solid tumors that have not responded to standard treatments. It uses immune cells from your own tumor to fight cancer, and researchers want to see if it is safe and effective.
This trial tests a new drug, HS-20117, for people with advanced solid tumors, especially certain types of lung cancer. It aims to see if the drug is safe and effective when other treatments have stopped working.
This trial tests an investigational medicine called HS-20117-2 for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if it is safe and if it might help shrink or control the tumor.
This trial is testing a new drug called HS-20105, given by injection, for people with advanced solid tumors that have stopped responding to standard treatments. The drug targets a protein on cancer cells to try to slow or stop their growth.
This study tests a new treatment that takes immune cells from a small piece of your tumor, grows them in a lab, and then puts them back into your body to fight the cancer. It is for people with advanced lung, cervical, or breast cancer who have already tried standard treatments.
This trial tests a new drug called HS-20122 in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.